bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite]
bromfenac
RxCUI: 1790146
What the CMS Formulary Data Shows for bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite]
Per the CMS 2026 Part D formulary file, bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite] (RxNorm concept RXCUI 1790146, generic name bromfenac) appears on 5 distinct formulary files spanning 36 Medicare Part D plan offerings - 0.7% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 3 to Tier 4, with a cross-plan average of Tier 3.2.
Real-world access to bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 144,112 Part D beneficiaries filled bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite] in 2023, with total plan-and-beneficiary spending of $94,508,695 and an average per-beneficiary annual cost of $655.80. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite] today.
Coverage Details
- Formularies covering
- 5
- Plans covering
- 36
- Coverage rate
- 0.7%
- Tier range
- Tier 3 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 144,112
- Total spending
- $94,508,695
- Avg per beneficiary
- $655.80
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite]
36 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST | T3 | No | $0 | NV |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST | T3 | No | $0 | NV |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST | T3 | No | $0 | NV |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST | T3 | No | $0 | NV |
| Prominence Giveback (HMO) | PROMINENCE HEALTHFIRST | T3 | No | $0 | NV |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T3 | No | $0 | FL |
| Prominence Giveback (HMO) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T3 | No | $0 | FL |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $0 | TX |
| Prominence Plus (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $0 | TX |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $0 | TX |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $0 | TX |
| Prominence Beyond (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $0 | TX |
| Prominence Giveback (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $0 | TX |
| Prominence Giveback (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $0 | TX |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $0 | TX |
| Prominence Beyond (HMO-POS) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $0 | TX |
| Prominence Dual (HMO D-SNP) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T3 | No | $0 | FL |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | PROMINENCE HEALTHFIRST | T3 | No | $0 | NV |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T3 | No | $0 | FL |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $0 | TX |
| Prominence Diabetes and Heart Care Plus (HMO C-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $0 | TX |
| Prominence Diabetes and Heart Giveback (HMO C-SNP) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $0 | TX |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST | T3 | No | $4.20 | NV |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST OF FLORIDA INC | T3 | No | $4.80 | FL |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST OF TEXAS | T3 | No | $4.80 | TX |
| Prominence Extra Help (HMO) | PROMINENCE HEALTHFIRST | T3 | No | $9.50 | NV |
| Health First Rewards H1099-014 (HMO) | HEALTH FIRST HEALTH PLANS | T4 | No | $0 | FL |
| Health First SunSaver H1099-016 (HMO) | HEALTH FIRST HEALTH PLANS | T4 | No | $0 | FL |
| Health First Complete Care H1099-023 (HMO) | HEALTH FIRST HEALTH PLANS | T4 | No | $0 | FL |
| Health First Emerald Plus H1099-024 (HMO) | HEALTH FIRST HEALTH PLANS | T4 | No | $0 | FL |
| Health First Premier Access H1099-025 (HMO-POS) | HEALTH FIRST HEALTH PLANS | T4 | No | $0 | FL |
| Health First Emerald Plus H1099-026 (HMO) | HEALTH FIRST HEALTH PLANS | T4 | No | $0 | FL |
| Health First Premier Access H1099-027 (HMO-POS) | HEALTH FIRST HEALTH PLANS | T4 | No | $0 | FL |
| Health First Emerald Plus H1099-028 (HMO) | HEALTH FIRST HEALTH PLANS | T4 | No | $0 | FL |
| Health First Value H1099-006 (HMO) | HEALTH FIRST HEALTH PLANS | T4 | No | $15.00 | FL |
| Health First Classic H1099-001 (HMO-POS) | HEALTH FIRST HEALTH PLANS | T4 | No | $49.40 | FL |
Frequently Asked Questions
Is bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite] covered by Medicare Part D?
Yes, bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite] is covered by 36 Medicare Part D plans (0.7% of all Part D formularies).
What tier is bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite] on Medicare Part D plans?
bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite] averages Tier 3.2 across Part D plans, ranging from Tier 3 to Tier 4.
Does bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite] require prior authorization?
0% of Part D formularies require prior authorization for bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite]?
In 2023, total Medicare Part D spending on bromfenac 0.75 MG/ML Ophthalmic Solution [Bromsite] was $94,508,695, covering 144,112 beneficiaries. The average spend per beneficiary was $655.80.
Read our methodology - how this data is sourced, computed, and verified.